Dario Neri

Dario Neri

Company: Philogen

Job title: Chief Executive Officer


Modulating the Therapeutic Activity of ADCs & SMDCs With Engineered Cytokine Products 2:30 pm

Understanding how the therapeutic activity of ADCs and SMDCs can be potentiated with certain antibody-cytokine fusion proteins Illustrating how antibody-cytokine fusions, based on interleukin-2 and capable of selective localisation at the tumour site, are particularly effective in boosting the activity of ADCs and SMDCs Discussing the role of NK cells and of T cellsRead more

day: Day Two

Industry Leaders Panel Discussion – Reviewing the Last Year & Creating Strategies to Further Develop ADCs Through 2022 9:30 am

Reviewing how breakthroughs in 2021 are shaping the ADC industry What decision are industry pioneers making to ensure continued progress within the ADC space (technical and business/partnership decisions)? Outlining the biggest challenges that ADC drug developers are facing in taking drugs from the bench to bedside Discussing methods to bring ADCs to earlier-line treatmentRead more

day: Day One

Chairperson’s Opening Remarks 8:50 am

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.